News | Press Releases


November 26, 2017

Toshiba Medical Expands Neuro MR Capabilities with Advanced Gradient Offering

Vantage Galan 3T XGO Edition with All-New Saturn X Gradient Provides 30 Percent Increase in SNR During Neuro MR Exams

Toshiba Medical expands neuro MR capabilities with the introduction of the all-new Saturn X Gradient on the Vantage Galan 3T XGO Edition.

CHICAGO, Nov. 26, 2017 – Building on its success with offering clinicians more advanced options for neuro MR imaging, Toshiba Medical, a Canon Group company, is demonstrating the Vantage Galan™ 3T XGO Edition with the all-new Saturn X Gradient (pending 510(k) clearance) at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, November 26 – December 1, 2017 (Booth #7330). The Saturn X Gradient features an advanced strength of 45 mT/m (milliTesla per meter) to offer health care providers fast, higher-resolution imaging, while continuing to deliver streamlined workflow and superior patient comfort.

The Saturn X Gradient on the Galan 3T XGO Edition comes with Toshiba Medical’s PUREGradient digital technology, which can provide up to 30 percent improved signal-to-noise ratio (SNR) for brain diffusion weighted imaging (DWI), resulting in even higher-resolution neuro images than previously offered. The Galan 3T XGO Edition offers the ability to conduct quick, comfortable and high-quality neuro imaging exams, and allows for faster sampling and higher-resolution images, thanks to PURERF and Saturn technologies. This, combined with the ability to stack protocol sequences, results in quick neuro exams, enabling healthcare providers to produce higher resolution images for myriad neuro exams in under five minutes.* The Galan 3T XGO Edition also offers Multiband SPEEDER technology, which allows for multiple slices to be acquired at the same time, reducing diffusion weighted imaging scan times by up to two times.

Beyond its neuro capabilities, the Galan 3T XGO Edition also offers enhanced cardiac capabilities, including T1 mapping that utilizes MOdified Look-Locker Inversion recovery (MOLLI) sequence and allows providers to acquire a more quantitative characterization of myocardial tissue within a single breath hold. Additionally, Phase Sensitive Inversion Recovery (PSIR) in the heart provides improved contrast in late-enhanced imaging and eliminates the need for inversion time (TI) calibration scan, allowing cardiac exams to be completed with fewer breath holds and greater patient comfort.

“The introduction of the new Galan 3T XGO Edition with the Saturn X Gradient builds on the successes we have seen with the Galan 3T and enables us to enhance our neuro imaging package,” said Dominic Smith, senior director, CT, PET/CT, and MR Business Units, Toshiba America Medical Systems, Inc. “We know health care providers have varied clinical imaging requirements. The introduction of this new, advanced gradient enables us to meet the diverse needs of the marketplace with new imaging opportunities while continuing to provide patients with a quiet and comfortable experience.”

For more information, visit Toshiba Medical’s website at www.medical.toshiba.com.

About Toshiba America Medical Systems, Inc.

Toshiba America Medical Systems, a Canon Group company headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment. For more information, visit Toshiba Medical’s website at www.medical.toshiba.com.

About Toshiba Medical

Toshiba Medical offers a full range of diagnostic medical imaging solutions including Ultrasound, CT, X-Ray, and MR, across the globe. As of December 2016, Toshiba Medical became a member of the Canon Group. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide so that together our industry-leading solutions deliver an enriched quality of life.

*Initial indications suggest the following neuro sequences can be performed in under five minutes: SAG T1, AX T2, AX T2 FLAIR, AX T2 and AX DWI/ADC.

Vantage Galan is a trademark of Toshiba Medical Systems Corporation.